Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127471901 | 12747190 | 1 | I | 20070328 | 20160620 | 20160915 | 20160915 | EXP | US-ENDO PHARMACEUTICALS INC.-2016-004071 | ENDO | 58.81 | YR | M | Y | 99.88000 | KG | 20160915 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127471901 | 12747190 | 1 | PS | FORTESTA | TESTOSTERONE | 1 | Topical | U | 21463 | GEL | QD | ||||||||
| 127471901 | 12747190 | 2 | SS | ANDROGEL | TESTOSTERONE | 1 | Unknown | 0 | GEL | QD | |||||||||
| 127471901 | 12747190 | 3 | SS | ANDROGEL | TESTOSTERONE | 1 | Unknown | 0 | GEL | QD | |||||||||
| 127471901 | 12747190 | 4 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | Unknown | U | 0 | INJECTION | /wk | ||||||||
| 127471901 | 12747190 | 5 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | Unknown | U | 0 | GEL | QD | ||||||||
| 127471901 | 12747190 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127471901 | 12747190 | 7 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127471901 | 12747190 | 8 | C | TOPAMAX | TOPIRAMATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127471901 | 12747190 | 9 | C | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127471901 | 12747190 | 10 | C | HCTZ | HYDROCHLOROTHIAZIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127471901 | 12747190 | 11 | C | RELPAX | ELETRIPTAN HYDROBROMIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127471901 | 12747190 | 12 | C | PREDNISONE TABLETS | PREDNISONE | 1 | Oral | 40256 | TABLETS | ||||||||||
| 127471901 | 12747190 | 13 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127471901 | 12747190 | 1 | Androgen replacement therapy |
| 127471901 | 12747190 | 2 | Androgen replacement therapy |
| 127471901 | 12747190 | 4 | Androgen replacement therapy |
| 127471901 | 12747190 | 6 | Hypothyroidism |
| 127471901 | 12747190 | 7 | Hyperlipidaemia |
| 127471901 | 12747190 | 8 | Product used for unknown indication |
| 127471901 | 12747190 | 9 | Product used for unknown indication |
| 127471901 | 12747190 | 10 | Product used for unknown indication |
| 127471901 | 12747190 | 11 | Product used for unknown indication |
| 127471901 | 12747190 | 12 | Product used for unknown indication |
| 127471901 | 12747190 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127471901 | 12747190 | DS |
| 127471901 | 12747190 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127471901 | 12747190 | Chronic obstructive pulmonary disease | |
| 127471901 | 12747190 | Deep vein thrombosis | |
| 127471901 | 12747190 | Pneumonia | |
| 127471901 | 12747190 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127471901 | 12747190 | 1 | 200608 | 201402 | 0 | |
| 127471901 | 12747190 | 2 | 200608 | 2012 | 0 | |
| 127471901 | 12747190 | 3 | 20140404 | 20140504 | 0 | |
| 127471901 | 12747190 | 4 | 201404 | 0 | ||
| 127471901 | 12747190 | 5 | 20140404 | 20140504 | 0 |